Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
PPAR Research is Scopus-indexed (Q1, CiteScore 7.8), WoS SCIE, DOAJ. Published by John Wiley and Sons Ltd.
Checked against the index lists dated .
ISSN 1687-4757Verify ISSN ↗1687-4765Verify ISSN ↗
Publisher: John Wiley and Sons Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 41 / 278 | 85th | Q1 |
| Drug Discovery | 36 / 161 | 77th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2006–present, best quartile Q1, CiteScore 7.8.
PPAR Research is Q1 in Pharmacology (medical) (rank 41 of 278) and Q1 in Drug Discovery (rank 36 of 161), by CiteScore 2025.
PPAR Research is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.8, which places it in quartile Q1 at the 85th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.000, quartile Q1, with an H-index of 65.
The publisher lists an article processing charge of about US$1,630 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
PPAR Research is published by John Wiley and Sons Ltd. Its print ISSN is 1687-4757 and its online ISSN is 1687-4765.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
PPAR Research has an h-index of 72 and a 2-year mean of 2.05 citations per paper (OpenAlex). Its Scopus CiteScore is 7.8, quartile Q1. On 2-year citations it ranks #126 of 271 Scopus journals in Pharmacology (medical).
PPAR Research published 5 papers in 2025; its busiest recent year was 2020 with 30. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 72 research articles (2021–2026), authors are most often from China (56.9%), United States (8.3%) and Mexico (6.9%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 10 retracted papers are recorded (14.5 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.